Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Double-patenting only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAUK TEODORO, PRICILA NMN | 1 | 75.0% | +0.0% |
| LI, RUIXIANG | 1 | 59.4% | +19.0% |
| SHUPE, ELIZABETH A | 1 | 64.7% | +47.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18003484 | METHODS AND COMPOSITIONS FOR CANCER TREATMENT | LI, RUIXIANG | — |
| 17919043 | PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF | SHUPE, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1674 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546077 | USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Final Rejection | — | Pending | Aug 10, 2023 |
| 18003484 | METHODS AND COMPOSITIONS FOR CANCER TREATMENT | LI, RUIXIANG | 1674 | DP | Non-Final OA | — | Pending | Dec 27, 2022 |
| 17919043 | PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF | SHUPE, ELIZABETH A | 1643 | §103 | Final Rejection | — | Pending | Oct 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial